Real‐world data prognostic model of overall survival in patients with advanced NSCLC receiving anti‐PD‐1/PD‐L1 immune checkpoint inhibitors as second‐line monotherapy

Abstract Background and aim The objective of this retrospective, observational, noninterventional cohort study was to investigate prognostic factors of overall survival (OS) in patients with advanced non‐small cell lung cancer (aNSCLC) and to develop a novel prognostic model. Methods A total of 4049...

Descripción completa

Detalles Bibliográficos

Autores principales:	Cristina Julian, Robson J. M. Machado, Sandhya Girish, Pascal Chanu, Dominik Heinzmann, Chris Harbron, Anda Gershon, Shannon M. Pfeiffer, Wei Zou, Valerie Quarmby, Qing Zhang, Yachi Chen
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2022-10-01
Colección:	Cancer Reports
Materias:	advanced NSCLC immune checkpoint inhibitors prognostic model real‐world data
Acceso en línea:	https://doi.org/10.1002/cnr2.1578
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!